GlassScriptPhysician profile
Cindy Y Li
NPI 1265509111
$17,276.54
in general payments reported to CMS, 2019-2025
48 companies · $3,297 in 2025
The $3,297 reported for 2025 was more than what 86% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,927 · 2020: $1,532 · 2021: $1,970 · 2022: $1,924 · 2023: $3,011 · 2024: $3,616 · 2025: $3,297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,814 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,813.59 |
| Education | $110.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,436.58 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $1,530.21 | 2019-2025 | Absorica Ld, Winlevi, Blu-U |
| Lilly USA, LLC | $1,468.19 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Pfizer INC. | $1,184.16 | 2019-2025 | |
| Amgen INC. | $969.87 | 2020-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $883.87 | 2019-2025 | |
| Ucb, INC. | $797.93 | 2019-2025 | Bimzelx, Cimzia |
| E.R. Squibb & Sons, L.L.C. | $769.61 | 2023-2025 | Sotyktu |
| Incyte Corporation | $710.30 | 2022-2025 | Opzelura |
| Janssen Biotech, INC. | $672.52 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Mayne Pharma Commercial LLC | $647.17 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $595.45 | 2019-2025 | Jublia, Arazlo, Duobrii |
| Galderma Laboratories, L.P. | $527.70 | 2019-2025 | Aklief, Oracea, Nemluvio |
| Arcutis Biotherapeutics, INC. | $507.97 | 2023-2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $422.84 | 2019-2025 | Dupixent, Libtayo |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.